Myriad Genetics Marking Prostate Cancer Awareness Month with Hereditary Testing Outreach

Myriad Genetics Marking Prostate Cancer Awareness Month with Hereditary Testing Outreach
Myriad Genetics is marking Prostate Cancer Awareness Month by highlighting the importance of assessing the hereditary risk of the disease. The company is using its myRisk Hereditary Cancer test in its public outreach effort in September. The tool identifies mutations in men diagnosed with prostate cancer. Myriad develops and commercializes molecular diagnostic tests that can determine the risk of developing a disease, assess the risk of it progressing, and guide patients' treatment decisions
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *